Pipeline Advancements Fuelled Mid-Cap Biotech Research and Development Spend in 2014

PharmaLeaders: Mid-Cap Biotechnology Benchmark Report – Sales Forecasts and Product Valuations of Innovative Biotechs

The combined spend on research and development for the peer group of 35 mid-cap biotech companies increased by nearly $2 billion to reach a total of $9.7 billion in 2014, primarily thanks to top spender Regeneron. The company led the way with R&D expenses of $860 million in 2013, further analysis shows that Regeneron’s R&D expenses grew by 47.9% year-to-year to $1.3 billion in 2014. Vertex had the second largest R&D outlay among the peer group, spending $855.5 million in 2014, representing a 3% decrease from 2013. This resulted from the company completing the TRAFFIC and TRANSPORT clinical trials evaluating VX-809, a combination product of lumacaftor and ivacaftor for treating cystic fibrosis.

Mid-Cap Biotechnology Benchmark Report applies a proprietary ranking methodology to compare the competitive positions of 35 mid-cap biotechnology companies on 14 financial metrics. Key questions answered:

  • What specific strategies are innovative biotech companies employing to gain market share?
  • What therapeutic areas are biotech companies allocating their R&D budgets?
  • Which trends will affect the sector moving forward?
  • How does my pipeline and commercialisation strategy match up against the competition?
  • What specific business development activities are taking place, in terms of partnerships or M&A?
  • What particular enabling technologies and drug platforms are companies developing?
  • How are companies maximising their capital spend to gain competitive advantage?

Benchmark your company’s performance against a similar peer group to assess areas of strength/weakness.

Anjali Kalan


Tagged: , , , , , , ,

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: